-phosphorylated CD4 peptides confirms that this phosphorylation does not meaningfully perturb the structure of the complex (20) . Dissociation may be induced by binding of the endocytic machinery to phosphorylated CD4, or it may involve recruitment of additional proteins that have not yet been recognized. The human immunodeficiency virus (HIV) protein Nef also induces Lck dissociation, as well as internalization and degradation of CD4, but in a manner that does not involve phosphorylation (27) . Interestingly, Nef recognizes residues 407 to 417 of CD4, suggesting that binding of this region may be sufficient to induce Lck dissociation in spite of the Zn 2ϩ center (19) . The zinc clasp may represent an evolutionary expedient that allows reuse of a single lck gene product as a de facto receptor tyrosine kinase in some developmental contexts and as a nonreceptor kinase in others. Furthermore, it allows the regulated release of CD4 for internalization. The motif is unlikely to be widely employed, as even within the Src family the requisite cysteine residues are unique to Lck. These structures are examples of metaldependent cofolding of two protein sequences. The underlying structural principle is general: Short polypeptide sequences, which are smaller and less well conserved than typical protein domains, can fold together to mediate specific, regulated protein interactions. This mechanism of interaction stands in contrast to the recognition of phosphotyrosine and prolinerich peptide motifs by the SH2 and SH3 domains of Lck, which typify modular protein interaction domains. It is unclear whether the N-terminal domain of Lck in complex with coreceptor represents a structurally isolated targeting mechanism or whether it may also affect Lck catalytic activity by impinging upon the regulatory interactions among the SH3, SH2, and kinase domains. Further investigation will be required to understand this issue and to understand precisely how the CD4-Lck complex is disrupted to allow coreceptor internalization. G protein-coupled receptors (GPCRs) at the cell surface activate heterotrimeric G proteins by inducing the G protein alpha (G␣) subunit to exchange guanosine diphosphate for guanosine triphosphate. Regulators of G protein signaling (RGS) proteins accelerate the deactivation of G␣ subunits to reduce GPCR signaling. Here we identified an RGS protein (AtRGS1) in Arabidopsis that has a predicted structure similar to a GPCR as well as an RGS box with GTPase accelerating activity. Expression of AtRGS1 complemented the pheromone supersensitivity phenotype of a yeast RGS mutant, sst2⌬. Loss of AtRGS1 increased the activity of the Arabidopsis G␣ subunit, resulting in increased cell elongation in hypocotyls in darkness and increased cell production in roots grown in light. These findings suggest that AtRGS1 is a critical modulator of plant cell proliferation.
Heterotrimeric G proteins couple multiple signal transduction pathways from seventransmembrane (7TM) GPCRs to downstream effectors in mammalian cells (1) . RGS proteins accelerate the intrinsic guanosine triphosphatase (GTPase) activity of the G␣ subunit, thus returning the heterotrimer to its basal GDP-bound state (2) . In contrast to metazoans, the Arabidopsis genome contains only one canonical G␣ subunit (AtGPA1), one G protein ␤ (G␤) subunit (AtAGB1), and two G protein ␥ (G␥) subunits (AtAGG1 and AtAGG2), and neither a 7TM receptor nor a cognate ligand has been identified in plants. Nonetheless, plants use heterotrimeric G protein signaling to regulate growth and development (3, 4) . The phenotypes of null mutants of the G␣ and G␤ subunits indicate that a heterotrimeric G protein controls cell proliferation processes in Arabidopsis (5, 6).
A search of the Arabidopsis genome database for other potential components of heterotrimeric G protein signaling (7) revealed a single open-reading frame (ORF) of 459 amino acids (aa), hereafter called AtRGS1, that encodes an extended N-terminal region and a C-terminal RGS box (Fig. 1) . The first 250 amino acids are predicted to form a 7TM domain with a topology reminiscent of GPCRs: an extracellular N-terminus and an intracellular Cterminus (Fig. 1A) . All other known RGS proteins lack 7TM domains. The 7TM region of AtRGS1 has weak overall similarity to the metabotropic glutamate GPCR subfamily ("Family C") that also includes calciumsensing, odorant, pheromone, and ␥-aminobutyric acid type B (GABA B ) receptors (8) . However, the large, ligand-binding, N-terminal ectodomain that typifies most members of this GPCR subfamily is lacking in the AtRGS1 ORF (Fig. 1A) . The predicted topology of AtRGS1 places cysteine residues (Cys 84 and Cys
153
) at the entry to transmembrane domain 3 (TM3) and the second extracellular loop ( fig.  S1 ), respectively, in similar positions to a common disulfide linkage found frequently in GPCRs of all subfamilies (9) . A database search of Arabidopsis ORFs using the N-and C-terminal domains of AtRGS1 failed to yield homologs; thus, it appears that AtRGS1 represents the single member of this family.
The C-terminal 211 amino acids (aa 249-459) of AtRGS1, which contains the RGS box was expressed and purified from E. coli as a glutathione S-transferase (GST) fusion protein (GST-RGS1box) and was tested for its ability to bind to and accelerate the GTPase activity of AtGPA1. GST-RGS1box associated with recombinant AtGPA1 in vitro ( Fig. 2A ). This interaction was dependent on the addition of aluminium tetrafluoride (AlF 4 -), a planar ion that stabilizes G␣ subunits in a transition state for GTP hydrolysis (10) . RGS box proteins that act as GTPaseaccelerating proteins (GAPs) for G␣ subunits bind most avidly to the GDP-AlF 4 -form of their G␣ subunit targets (10) . GST-RGS1box also accelerated the GTPase activity of AtGPA1 in a dose-dependent manner (Fig. 2 , B and C). A 14-fold increase in inorganic phosphate production was observed at a threefold excess of GTPloaded AtGPA1 over GST-RGS1box protein.
Loss-of-function mutations to Sst2, the archetypal RGS protein of the budding yeast Saccharomyces cerevisiae, render haploid yeast supersensitive to pheromone signaling that is mediated by a canonical GPCR-linked signal transduction pathway (11) . The C-terminal domain of AtRGS1 (AtRGS1box; aa 249 -459) was tested for its ability to complement the (15), is plotted below the schematic representation of the AtRGS1 ORF (GenPept accession number NP_189238). (B) Multiple sequence alignment of the RGS box regions of human hRGS19, rat rRGS4, bovine bRGS9, and Arabidopsis AtRGS1 proteins. Conserved amino acids identified by ClustalW (16) are boxed in black. The nine ␣ helices observed within the nuclear magnetic resonance (NMR) solution structure (17) of hRGS19 are numbered with roman numerals and overlined in blue. Closed circles denote conserved residues forming the RGS box hydrophobic core; open circles highlight conserved residues making direct contacts with G␣ in the RGS4/G␣i1 crystal structure (10) . Predicted ␣ helical (␣) and ␤ strand (␤) secondary structure within the AtRGS1 RGS box, based on the PSI-Pred algorithm (18) , is denoted underneath the AtRGS1 sequence. Primary sequences in the alignment are human hRGS19/GAIP (SwissProt accession number P49795), rat rRGS4 (P49799), bovine bRGS9 (O46469), and AtRGS1 (GenPept NP_189238). -and then precipitated with glutathione agarose. Complex formation was detected by immunoblotting (IB) with specific antibodies as indicated. (B) GSTRGS1box accelerates the intrinsic GTPase activity of AtGPA1 in vitro. Single-turnover GTPase assays, using GTP-loaded His 6 -AtGPA1 (575 nM) in the absence or presence of 182 nM GSTRGS1box protein, were initiated with the addition of 5 mM MgCl 2 at 0 s. Inorganic phosphate release was measured in real-time using fluorescent phosphate binding protein [ ex ϭ 425 nm, em ϭ 465 nm (excitation and emission wavelengths, respectively)] and is expressed as change in fluorescence units over time (19) . Basal level of protein-independent inorganic phosphate production is also denoted (CONTROL). (C) Dose-dependent AtRGS1 GAP activity. Single turnover GTPase assays were performed as in (B) using 500 nM AtGPA1 and varying concentrations of GST-RGS1box protein (0 to 4.6 M). The apparent initial rate of phosphate production (k obs in s supersensitivity phenotype of the yeast Sst2 deletion mutant, sst2⌬. As observed with some mammalian RGS proteins, expression of AtRGS1 box partially restored the normal doseresponse curve for ␣ factor pheromone induction of ␤-galactosidase reporter gene expression placed under the control of a pheromone pathway-specific promoter ( pFUS1-lacZ) (11), suggesting that the C-terminal domain of AtRGS1 exerts GAP activity on the yeast G␣ subunit Gpa1. In addition, halo assays of pheromoneinduced lethal arrest also revealed that expression of this domain can attenuate the pheromone supersensitivity of haploid sst2⌬ yeast (7) (fig. S2) .
Interaction between full-length AtRGS1 and AtGPA1 was shown by complementation of split ubiquitin domain fusions in yeast (12) . The isolated AtRGS1 C-terminus [AtRGS1(⌬7TM); aa 249-459], as well as the full-length AtRGS1, interacted with both a constitutively active, GTPase-deficient form [Gln ) and wildtype AtGPA1 (Fig. 3A) . However, the N-terminal 7TM domain of AtRGS1 [AtRGS1(⌬RGS); aa 1-248] did not interact with AtGPA1 in this assay. Full-length AtRGS1 fused to a c-myc epitope tag (AtRGS1-myc) was immunoprecipitated from Arabidopsis cell lysates with antiserum to AtGPA1, preferentially in the presence of AlF 4 - (Fig. 3B ). In the reciprocal experiment, AtGPA1 immunoprecipitated with antibody to myc, also preferentially in the presence of AlF 4 -. These results indicate that the full-length AtRGS1 protein interacts with endogenous AtGPA1 preferentially in the transition-state mimetic form and, thus, has the property of an RGS protein in vivo.
Expression of AtRGS1 and AtGPA1 as fusions with green fluorescent protein (AtRGS1-GFP and AtGPA1-GFP) showed localization of both proteins to the plasma membranes of postmitotic cells in culture (Fig. 3C) . Plasma membrane localization of AtRGS1-GFP was maintained in fully differentiated, postmitotic cells in the intact root (Fig. 3D) . In dividing Arabidopsis cells, both proteins accumulated at the nascent cell plate (Fig. 3, E and F) , suggesting a role in cytokinesis.
Null alleles of AtGPA1 have reduced proliferation of some cell types throughout development (5, 6) . Therefore, we expected that if AtRGS1 is a negative regulator of AtGPA1, null mutants of AtRGS1 (Atrgs1-1, Atrgs1-2) would exhibit increased proliferation of some cell types, and AtRGS1 should be expressed in some or all sites of stem cell proliferation. An AtRGS1::GUS transcriptional fusion transgene was predominantly expressed in shoot and root apical meristems where AtGPA1 is also expressed (13) (Fig. 4E) . Atrgs1 null mutant seedlings (Fig. 4, A and B) had longer hypocotyls in the dark as a result of increased cell elongation ( Fig. 4C; fig. S3 ). In contrast, null alleles of AtGPA1 (Atgpa1-1 3 -4) (5, 14) caused shorter hypocotyls, although this phenotype is due to fewer cells (5) . Expression of the constitutively active AtGPA1 QL increased etiolated hypocotyl length due to increased cell elongation, similar to the Atrgs1-null mutants (Fig. 4, C and G) .
In light-grown seedlings, both null mutants of AtRGS1 and lines overexpressing AtGPA1 QL produced longer primary roots compared with wild-type Arabidopsis or null mutants of AtGPA1 (Fig. 4D) . This increased root growth phenotype resulted from increased cell production in root meristems (Fig. 4G) . These data suggest that increased activity of AtGPA1, either by expression of constitutively active AtGPA1
QL or through loss of AtRGS1 expression, results in increased cell proliferation in the apical root meristem. Inducible overexpression of AtRGS1 (7) (fig. S4 ) produced a similar phenotype as loss of AtGPA1 (Fig. 4F) , further suggesting that AtRGS1 antagonizes the activation of AtGPA1. In addition, some lossof-function gpa1 phenotypes, such as paclobutrazol and sugar sensitivity, are the opposite in the Atrgs1 mutants, indicating a role for activated GPA1 in other signaling pathways throughout development (figs. S5 and S6).
Heterologous expression of full-length AtRGS1 protein in Sf9 insect cells has not yet provided adequate expression levels for a biochemical test of GAP activity in vitro. Nevertheless, the evidence that null mutants of AtRGS1 phenocopy the constitutively active mutant form of AtGPA1 (AtGPA1 QL ), that overexpression of AtRGS1 antagonizes the activation of AtGPA1 (Fig. 4) , and that full-length AtRGS1 interacts with AtGPA1 in an AlF 4 --dependent manner (Fig. 3) suggests that AtRGS1 exerts GAP activity on AtGPA1 in vivo. Our results here support earlier findings that cell proliferation in plants is regulated by heterotrimeric G protein subunits and further extend those findings by showing that this regulation is cell type specific. It also reveals that cell proliferation control by the Arabidopsis G protein mechanistically involves either the unsequestered G␤␥ subunit or the activated G␣ subunit as the predominant regulatory element, depending on cell type. Here we show that in Drosophila, DR extends life-span entirely by reducing the short-term risk of death. Two days after the application of DR at any age for the first time, previously fully fed flies are no more likely to die than flies of the same age that have been subjected to long-term DR. DR of mammals may also reduce short-term risk of death, and hence DR instigated at any age could generate a full reversal of mortality.
Dietary restriction (DR) prolongs life-span and delays the onset of many age-related declines in function (1) (2) (3) (4) . In Drosophila, DR is applied by maintenance of adult flies on a food medium that contains roughly 35% less yeast and sugar than standard laboratory medium (2, 5) . Both mean and maximum life-span are increased under DR conditions (5). Age-specific mortality is a measure of the instantaneous hazard of death for an individual at a given age. Unlike survivorship analysis, which is a cumulative measure, age-specific mortality allows independent comparisons of vulnerability to death at different ages (6, 7 ). In Drosophila, chronic DR results in a delay in the onset of a detectable aging-related increase in mortality (5) . Once the mortality increase is detected, however, it proceeds at roughly the same rate in DR and control flies (5) . Interventions can lower adult mortality by slowing the accumulation of the irreversible damage that is characteristic of aging (aging-related damage), by reducing short-term vulnerability to death (risk), or by some combination of the two (8) . We can distinguish these hypotheses experimentally for DR by examining the effect of past and current nutritional conditions on age-specific mortality. This type of approach has shown that, in Drosophila, increased reproductive activity in males (8) and yeast deprivation in females (9) result in a higher mortality that is entirely due to an increased risk of death. In contrast, Mediterranean fruit flies (Ceratitis capitata) switched from sugar only to sugar and yeast food were permanently affected by their previous diet (10) . If DR acts solely by slowing the accumulation of agingrelated damage, then the onset of DR would not lead to a drop in mortality rate, because the damage would not be reversed. However, DR would result in a slower subsequent accumulation of aging-related damage and, hence, a less rapid subsequent increase in
